RenovoRx
PublicRenovoRx is now publicly traded
The data on this page reflects RenovoRx's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Private Placement
Mar 20, 2026
Total Funding Raised
$33.35M
Company Overview
RenovoRx has raised $33.35M. It was founded in 2009.
RenovoRx is a clinical-stage biopharmaceutical company that develops targeted oncology therapies and commercializes the RenovoCath drug-delivery device.
AI Layer
Non-AI
RenovoRx Comparables
Compare RenovoRx with similar companies based on industry and business-model similarity.
No comparables are published for RenovoRx. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
RenovoRx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Mar 20, 2026 | ||||
| Private Placement | Apr 11, 2024 | ||||
| Private Placement | Apr 18, 2018 | ||||
| Private Placement | Dec 7, 2015 | ||||
| Private Placement | Dec 20, 2013 | ||||
Private Placement | Jan 23, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
RenovoRx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pathfinder Asset Management Limited | Private Placement |
| Transcend Partners | Private Placement |
| Bleichroeder | Private Placement |
RenovoRx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.